Inactivation of Bcl-2 by phosphorylation - PubMed (original) (raw)
Inactivation of Bcl-2 by phosphorylation
S Haldar et al. Proc Natl Acad Sci U S A. 1995.
Abstract
The antiapoptosis potential of Bcl-2 protein is well established, but the mechanism of Bcl-2 action is still poorly understood. Using the phosphatase inhibitor okadaic acid or the chemotherapeutic drug taxol, we found that Bcl-2 was phosphorylated in lymphoid cells. Phospho amino acid analysis revealed that Bcl-2 was phosphorylated on serine. Under similar conditions, okadaic acid or taxol treatment led to the induction of apoptosis in these cells. Thus, phosphorylation of Bcl-2 seems to inhibit its ability to interfere with apoptosis. In addition, phosphorylated Bcl-2 can no longer prevent lipid peroxidation as required to protect cells from apoptosis.
Similar articles
- Antiapoptosis potential of bcl-2 oncogene by dephosphorylation.
Haldar S, Jena N, Croce CM. Haldar S, et al. Biochem Cell Biol. 1994 Nov-Dec;72(11-12):455-62. doi: 10.1139/o94-061. Biochem Cell Biol. 1994. PMID: 7654318 - T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M, Malipiero U, Groscurth P, Fontana A. Weller M, et al. Exp Cell Res. 1995 Dec;221(2):395-403. doi: 10.1006/excr.1995.1390. Exp Cell Res. 1995. PMID: 7493639 - Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A.
Kiguchi K, Glesne D, Chubb CH, Fujiki H, Huberman E. Kiguchi K, et al. Cell Growth Differ. 1994 Sep;5(9):995-1004. Cell Growth Differ. 1994. PMID: 7819137 - Interleukin 2 regulates Raf-1 kinase activity through a tyrosine phosphorylation-dependent mechanism in a T-cell line.
Turner BC, Tonks NK, Rapp UR, Reed JC. Turner BC, et al. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5544-8. doi: 10.1073/pnas.90.12.5544. Proc Natl Acad Sci U S A. 1993. PMID: 7685905 Free PMC article. - Okadaic acid-induced lens epithelial cell apoptosis requires inhibition of phosphatase-1 and is associated with induction of gene expression including p53 and bax.
Li DW, Fass U, Huizar I, Spector A. Li DW, et al. Eur J Biochem. 1998 Oct 15;257(2):351-61. doi: 10.1046/j.1432-1327.1998.2570351.x. Eur J Biochem. 1998. PMID: 9826180
Cited by
- BCL-XL regulates the timing of mitotic apoptosis independently of BCL2 and MCL1 compensation.
Yu CY, Yeung TK, Fu WK, Poon RYC. Yu CY, et al. Cell Death Dis. 2024 Jan 3;15(1):2. doi: 10.1038/s41419-023-06404-9. Cell Death Dis. 2024. PMID: 38172496 Free PMC article. - Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy.
Wei L, Zhang Q, Zhong C, He L, Zhang Y, Armaly AM, Aubé J, Welch DR, Xu L, Wu X. Wei L, et al. Mol Oncol. 2023 Oct;17(10):1962-1980. doi: 10.1002/1878-0261.13478. Epub 2023 Jul 19. Mol Oncol. 2023. PMID: 37357618 Free PMC article. - Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian Cancer Cell via mTORC1/S6K Signaling Pathway.
Kim G, Jang SK, Kim YJ, Jin HO, Bae S, Hong J, Park IC, Lee JH. Kim G, et al. Int J Mol Sci. 2022 Aug 6;23(15):8761. doi: 10.3390/ijms23158761. Int J Mol Sci. 2022. PMID: 35955892 Free PMC article. - HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells.
Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit LO, Samankul A, Leerat C, Senawong T. Namwan N, et al. Molecules. 2022 Jun 22;27(13):4014. doi: 10.3390/molecules27134014. Molecules. 2022. PMID: 35807258 Free PMC article. - Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine.
Dhyani P, Quispe C, Sharma E, Bahukhandi A, Sati P, Attri DC, Szopa A, Sharifi-Rad J, Docea AO, Mardare I, Calina D, Cho WC. Dhyani P, et al. Cancer Cell Int. 2022 Jun 2;22(1):206. doi: 10.1186/s12935-022-02624-9. Cancer Cell Int. 2022. PMID: 35655306 Free PMC article. Review.
References
- Annu Rev Biochem. 1989;58:453-508 - PubMed
- Exp Cell Res. 1991 Jul;195(1):237-46 - PubMed
- Arch Biochem Biophys. 1994 Dec;315(2):483-8 - PubMed
- Cancer Res. 1994 Apr 15;54(8):2095-7 - PubMed
- Nature. 1980 Apr 10;284(5756):555-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources